Anthony Lang

A major locus for myoclonus-dystonia maps to chromosome 7q in eight families.

Long-term hardware-related complications of deep brain stimulation.

Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease.

Neonatal ablation of the nigrostriatal dopamine pathway does not influence limb development in rats.

Predicting motor decline and disability in Parkinson disease: a systematic review.

Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging.

Acute effect of transcutaneous electrical nerve stimulation on tremor.

Neurodegenerative disease and the evolution of art: the effects of presumed corticobasal degeneration in a professional artist.

Pallidal neuronal activity: implications for models of dystonia.

Psychogenic movement disorders.

Tics.

Unique form of propriospinal myoclonus as a possible complication of an enteropathogenic toxin.

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.

Corticobasal degeneration: selected developments.

Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.

Subthalamic stimulation for Parkinson's disease--living better electrically?

Motor cortical stimulation for parkinsonism in multiple system atrophy.

Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor.

Posttraumatic painful torticollis.

Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study.

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.

Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.

Gestes antagonistes in psychogenic dystonia.

Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.

Sporadic case of dentatorubral pallidoluysian atrophy with no CAG repeat expansion and no intranuclear inclusions.

Clinical findings in a large family with a parkin ex3delta40 mutation.

Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease.

Presentation of Creutzfeldt-Jakob disease as acute corticobasal degeneration syndrome.

Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: clinical and electrophysiological observations.

Neuronal activity in the globus pallidus of multiple system atrophy patients.

Analysis of the glucocerebrosidase gene in Parkinson's disease.

Genetic association study of PINK1 coding polymorphisms in Parkinson's disease.

Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease.

Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.

Apraxia in movement disorders.

Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients.

Atypical absences and recurrent absence status in an adult with Angelman syndrome due to the UBE3A mutation.

Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery.

Progress in clinical neurosciences: a forum on the early management of Parkinson's disease.

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.

Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.

Cardiac valvulopathy associated with pergolide use.

Cortical and spinal abnormalities in psychogenic dystonia.

Subthalamic nucleus stimulation: improvements in outcome with reprogramming.

Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.

Rapidly progressive sporadic dentatorubral pallidoluysian atrophy with intracytoplasmic inclusions and no CAG repeat expansion.

Criteria for deep-brain stimulation in Parkinson's disease: review and analysis.

Punding prevalence in Parkinson's disease.

Interhemispheric and ipsilateral connections in Parkinson's disease: relation to mirror movements.

Changes in cortical and pallidal oscillatory activity during the execution of a sensory trick in patients with cervical dystonia.

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.

Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease.

Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse.

Characterization of REM-sleep associated ponto-geniculo-occipital waves in the human pons.

Benign hereditary chorea revisited: a journey to understanding.

Subdural motor cortex stimulation in Parkinson's disease does not modify movement-related rCBF pattern.

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

The many faces of corticobasal degeneration.

rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET study.

Electrophysiological features of myoclonus-dystonia.

Levodopa-related motor complications--phenomenology.

Reduced intracortical and interhemispheric inhibitions in corticobasal syndrome.

Non-dopaminergic treatments in development for Parkinson's disease.

Understanding disability in Tourette syndrome.

When and how should treatment be started in Parkinson disease?

Peroxisomal D-bifunctional protein deficiency: three adults diagnosed by whole-exome sequencing.

Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study.

Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study.

Psychogenic movement disorders.

Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons.

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

Urate as a predictor of the rate of clinical decline in Parkinson disease.

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease.

Stimulation of the subthalamic nucleus and impulsivity: release your horses.

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

Extrastriatal dopaminergic dysfunction in tourette syndrome.

Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD).

Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia.

Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation.

A survey on the impact of the menstrual cycle on movement disorders severity.

Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future.

Involvement of the cerebellothalamocortical pathway in Parkinson disease.

Potential placebo effect in assessing idiopathic normal pressure hydrocephalus.

A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.

Tongue control for swallowing in Parkinson's disease: effects of age, rate, and stimulus consistency.

Psychogenic movement disorders: past developments, current status, and future directions.

Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease.

Deep brain stimulation for dystonia.

The curious case of phenocopies in families with genetic Parkinson's disease.

Development of a non-motor fluctuation assessment instrument for Parkinson disease.

Movement disorders on YouTube--caveat spectator.

Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.

Acquired neurosyphilis presenting as movement disorders.

Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples.

Premotor Parkinson's disease: concepts and definitions.

Associated movement disorders in orthostatic tremor.

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Caffeine for treatment of Parkinson disease: a randomized controlled trial.

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.

Investigation of C9orf72 in 4 Neurodegenerative Disorders.

Clinicopathological review of pallidonigroluysian atrophy.

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.

α-Synuclein oligomers and clinical implications for Parkinson disease.

Voxel-based imaging of translocator protein 18 kDa (TSPO) in high-resolution PET.

Caffeine consumption and risk of dyskinesia in CALM-PD.

The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders.

Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.

Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions.

Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.

The treatment of dystonic tremor: a systematic review.

Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy.

The prion hypothesis in Parkinson's disease: Braak to the future.

Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.

Implications of nocturnal symptoms towards the early diagnosis of Parkinson's disease.

A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.

Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses.

Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.

Pharmacological treatment of Parkinson disease: a review.

Bilateral pallidal stimulation for sargoglycan epsilon negative myoclonus.

Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome.

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.

Initiating dopaminergic treatment in Parkinson's disease.

Investing in the future: stimulation of the medial prefrontal cortex reduces discounting of delayed rewards.

Mutation analysis of patients with neurodegenerative disorders using NeuroX array.

Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better.

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

In pursuit of prodromal Parkinson's disease.

Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.

Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography.

Practical guidelines for managing adults with 22q11.2 deletion syndrome.

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.

Response to clozapine in a clinically identifiable subtype of schizophrenia.

The long-term outcome of orthostatic tremor.

Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.

Mutation analysis of CHCHD10 in different neurodegenerative diseases.

Minimal change multiple system atrophy: an aggressive variant?

Parkinson's disease.

Vascular Parkinsonism: deconstructing a syndrome.

Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.

Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.

Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease.

Disease-modifying strategies for Parkinson's disease.

Genome-wide variant by serum urate interaction in Parkinson's disease.

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study.

Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.

Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.

Progression of neuropsychiatric and cognitive features due to exons 2 to 5 deletion in the epsilon-sarcoglycan gene: a case report.

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.

Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease.

Contribution of insula in Parkinson's disease: A quantitative meta-analysis study.

Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects.

Unusual tremor syndromes: know in order to recognise.

Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.

Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.

Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.

Launching the movement disorders society genetic mutation database (MDSGene).

Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.

Appendectomy in mid and later life and risk of Parkinson's disease: A population-based study.

A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.

Long-term double-blinded unilateral pedunculopontine area stimulation in Parkinson's disease.

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.

The Saskatchewan Movement Disorders Program: Commitment Pays Off.

Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.

'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?

Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!

α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.

Disrupted Nodal and Hub Organization Account for Brain Network Abnormalities in Parkinson's Disease.

Alternating Hemiplegia of Childhood as a New Presentation of Adenylate Cyclase 5-Mutation-Associated Disease: A Report of Two Cases.

Basal ganglia calcification in a case of PKAN.

Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.

Precision medicine for disease modification in Parkinson disease.

Essential pitfalls in "essential" tremor.

Tracking the course of prodromal Parkinson's disease.

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.

Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.

Adult motor phenotype differentiates Dravet syndrome from Lennox-Gastaut syndrome and links SCN1A to early onset parkinsonian features.

Peduncolopontine nucleus stimulation in progressive supranuclear palsy: a randomised trial.

Oculogyric crises: A review of phenomenology, etiology, pathogenesis, and treatment.

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

Parkinson disease.

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.

Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease.

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Progressive ataxia and palatal tremor: Two autopsy cases of a novel tauopathy.

Alcohol improves cerebellar learning deficit in myoclonus-dystonia: A clinical and electrophysiological investigation.

[F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP.

Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.

Altered gut microbiome and metabolome in patients with multiple system atrophy.

Impaired emotion processing in functional (psychogenic) tremor: A functional magnetic resonance imaging study.

Lymphatic vasculature in human dural superior sagittal sinus: Implications for neurodegenerative proteinopathies.

Is there even such a thing as "idiopathic normal pressure hydrocephalus"?

Asymmetric neuromodulation of motor circuits in Parkinson's disease: The role of subthalamic deep brain stimulation.

What is "essential" about essential tremor? A diagnostic placeholder.

Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease.

Pallidal deep brain stimulation modulates cortical excitability and plasticity.

[F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy.

Actigraphy Detects Greater Intra-Individual Variability During Gait in Non-Manifesting LRRK2 Mutation Carriers.

Functional neurological disorders in Parkinson disease.

Oculogyric crises in PLA2G6 associated neurodegeneration.